The combat dressing market is anticipated to flourish at an average CAGR of 2.4% between 2023 and 2033. The market is expected to hold a market share of US$ 6.9 million by 2033 while the market is likely to reach a value of US$ 5.5 million in 2023.
A combat dressing or battle dressing is a kind of bandage intended to be carried by soldiers for immediate use in case of (typically gunshot) wounds. It consists of a large pad of absorbent cloth, attached to the middle of a strip of thin fabric used to bind the pad in place. Also, field dressings are issued in sealed waterproof pouches to keep them clean and dry. The pouch can be torn open when required.
The growth is attributed to an antibacterial barrier on the combat dressings that quickly stops the uncontrolled external hemorrhaging within 2-3 minutes. The antibacterial sealing of the bandage also helps to heal the wound hastily. While using this bandage, direct manual pressure can apply and maintain for at least 2 minutes to help control the bleeding.
The increasing investment by the government is a significant role in better healthcare and is expected to drive the market. Further, the companies are engrossed in introducing products for combat dressing, which is another factor that is anticipated to boost the growth of the combat dressing market during the forecast period.
Attributes | Details |
---|---|
Combat Dressing Market CAGR (2023 to 2033) | 2.4% |
Combat Dressing Market Size (2023) | US$ 5.5 million |
Combat Dressing Market Size (2033) | US$ 6.9 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising threat of terrorism is one of the key factors that is expected to fuel the growth of the combat dressing market over the analysis period. In addition, the increasing adoption of combat dressing products during the war by the US militants is also expected to augment the growth of the global market of combat dressing in the forthcoming years.
The market revenue is driven by increasing demand for these dressings during increasing war and terrorism, worldwide. In 2016, the Institute of Economics and Peace (IPE) compiled the 10 countries under the heavy influence of terrorism including Iraq, Afghanistan, Nigeria, Pakistan, Syria, Yemen, India, Somalia, Egypt, and Libya.
The expansion is also resulting as a consequence of increasing investments by the USA Department of Defense. According to the Congressional Research Service, on March 28, 2022, President Biden submitted his Fiscal Year (FY) 2023 budget request to Congress. Discretionary funding in the Department of Defense (DOD) budget request totals $773.0 billion, including US$ 55.8 billion (7.2%) to fund the Military Health System (MHS).
Product launches such as the launch of QuikClot by Z-Medica in January 2018 are expected to boost market growth. It is a hemostatic device, which stops bleeding significantly faster and is more effective than standard gauze. Since the adoption of QuikClot combat gauze by the United States Army Institute for Surgical Research (USAISR), the Naval Medical Research Center (NMRC), and the Committee on Tactical Combat Casualty Care (CoTCCC), over six million units of QuikClot combat gauze has been sold in 2018.
Certain factors are expected to act as restraints despite all the favorable conditions for the growth of the global combat dressing market. The lack of knowledge and the lack of awareness of using these products is one of the key factors that is anticipated to impede the growth of the combat dressing market. In addition to this, the heightened use of general and conventional dressings for war wounds is another factor that is hindering the combat dressing market growth.
Tourniquets actively serve as an alternative to combat dressing as it is the equipment used for stopping the blood flow from an injury. In March 2020, Alliance Rubber Company announced the immediate availability of latex-free tourniquets combined with antimicrobial protection, hindering market growth.
Limited awareness about the diseases, high cost of products, low economical conditions, and lack of favorable insurance systems are some major factors that are expected to hamper the adoption of Combat Dressing products across developing regions of the globe, which in turn will limit the market growth.
Countries | Revenue Share % (2022) |
---|---|
The United States | 36.9% |
Germany | 6.1% |
Japan | 3.9% |
North America | 41.3% |
Europe | 26.3& |
Countries | CAGR % (2023 to 2033) |
---|---|
China | 2.9% |
India | 2.4% |
The United Kingdom | 1.7% |
Australia | 2.1% |
In terms of regional platforms, North America holds a notable market share in the combat dressing market. The region held a market share of 41.3% share in 2022. North America, being a mature market, is expected to lead in the global combat dressing market share, over the forecast period, owing to a large consumer base, combined with a high military health budget.
Increasing awareness and availability of a wide range of combat dressing products such as Quikclot gauze, Celox gauze, and HemCon bandages increase the market growth in the region. In 2018, the United States Army developed Intrepid Dynamic Exoskeleton Orthosis (IDEO), which enhanced the movement of those with lower-limb injuries.
Europe is a hotspot of technological advancement in the medical field. Europe is also contributing moderate shares to the market due to the advanced medical facilities and easy availability of combat dressing in the market. Moreover, the medical industry present in Germany is largely contributing to the growth of the combat dressing market in Europe. Thus, owing to the aforementioned reasons, Europe held a market share of 26.3% in 2022.
According to Future Market Insights, Asia-Pacific is expected to grow with lucrative growth opportunities for the combat dressing market and held a significant share of 21.8% in 2022.
The increasing investment by the government in Asia-Pacific is a significant role in better healthcare and is one of the key factors expected to boost the growth of the combat dressing market during the forecast period.
Asia Pacific is the leading region in the combat dressing market owing to army conflicts in the region. According to the United States Army Medical Command 2016, survival rates of soldiers increased by 75% in Vietnam in 2016 due to the availability of proper combat dressing.
According to Future Market Insights, the Middle East & Africa are expected to provide significant growth opportunities for the market as it held a share of 13.0% in 2022. Companies in the region are engrossed in introducing new products for combat dressing, which is another factor that is anticipated to escalate the growth of the market in the forthcoming years.
As per the USA Army Medical Command 2016, in the Middle East, the lives of around 92% of soldiers wounded in Iraq and Afghanistan in 2018 were saved due to the availability of healthcare facilities. These healthcare facilities include combat dressing products. This is a vital factor that is expected to propel the growth of the market during the forecast period.
Category | By Product |
---|---|
Leading Segment | Combat Gauze |
Market Share (2022) | 32.1% |
Category | By Distribution Channel |
---|---|
Leading Segment | Retail Sales |
Market Share (2022) | 58.3% |
Based on product type, the combat gauze segment held a market share of 32.1% in 2022 whereas the distribution channel category is led by the retail sales segment with a market share of 58.3% in 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
There are many prominent market players in the combat dressing market such as Imbed Biosciences, Kane Biotech, Grapheal, Axio, and Guard Medical. Gecko, Adhesys Medical, Kerecis, Acera Surgical, and Cresilon, among others, are working hand-in-hand to provide the best-in-class combat dressing for enhancing the global arena. However, there are many global start-ups in the combat dressing market, which are stepping forward in matching the requirements of the combat dressing domain.
Some of the key participants present in the global combat dressing market include First Care Products, TyTek Group., PerSys Medical, IBC, 3M, B. Braun Holding, Medline Industries, Smith & Nephew, Medtronic, Performance Systems, SP Services, Jax First Aid, Tacmed Australia, and H&H Medical Corporation, among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as First Care Products, TyTek Group., and PerSys Medical, account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.
Recent Developments
The combat dressing market is currently valued at US$5.5 million in 2023.
The combat dressing market is likely to surpass US$ 6.9 million, exhibiting a slow-paced CAGR of 2.4% through 2033.
North America's ascent in the combat dressing market, with 41.3% market share, is driven by strong military and defense sector demand.
Combat gauze claims dominance in the combat dressing market, boasting a 32.1% market share due to its proven efficacy in rapidly stopping severe bleeding.
Innovations in materials technology offer lighter and more effective combat dressings, enhancing survivability and efficiency in critical situations.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Combat Gauze 5.3.2. Combat Eye-Shield 5.3.3. Combat Cravat 5.3.4. Combat Bandages 5.3.5. Needles 5.3.6. Combat Safety Pins 5.3.7. Nitrile Combat Gloves 5.3.8. Other Products 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033 6.3.1. Retail Stores 6.3.2. Online Stores 6.3.3. Other Healthcare Facilities 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product Type 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Product Type 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Product Type 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Product Type 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product Type 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product Type 14.2.3. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Distribution Channel 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product Type 15.1.2.2. By Distribution Channel 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product Type 15.2.2.2. By Distribution Channel 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product Type 15.3.2.2. By Distribution Channel 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product Type 15.4.2.2. By Distribution Channel 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product Type 15.5.2.2. By Distribution Channel 15.6. United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product Type 15.6.2.2. By Distribution Channel 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product Type 15.7.2.2. By Distribution Channel 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product Type 15.8.2.2. By Distribution Channel 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product Type 15.9.2.2. By Distribution Channel 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product Type 15.10.2.2. By Distribution Channel 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product Type 15.11.2.2. By Distribution Channel 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product Type 15.12.2.2. By Distribution Channel 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product Type 15.13.2.2. By Distribution Channel 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product Type 15.14.2.2. By Distribution Channel 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product Type 15.15.2.2. By Distribution Channel 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product Type 15.16.2.2. By Distribution Channel 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product Type 15.17.2.2. By Distribution Channel 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product Type 15.18.2.2. By Distribution Channel 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product Type 15.19.2.2. By Distribution Channel 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product Type 15.20.2.2. By Distribution Channel 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Product Type 15.21.2.2. By Distribution Channel 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Product Type 15.22.2.2. By Distribution Channel 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Product Type 15.23.2.2. By Distribution Channel 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By Distribution Channel 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. First Care Products 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. TyTek Group 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. PerSys Medical 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. IBC 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. H&H Medical Corporation 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Boumd Tree Medical 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Teleflex 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Celox Medical 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. 3M 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. B. Braun 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Medtronic 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports